Manufacturing · The complete guide

Potency Factor

TL;DR

Potency Factor (PF) is the dimensionless scalar that lets a Master Manufacturing Record written for a reference potency be executed against real lots whose certificates of analysis report different measured potencies. PF = reference potency ÷ measured potency, evaluated on a like-for-like basis (anhydrous, free-base, on-dry, marker-compound, activity-unit), and the adjusted dispense quantity is nominal target × PF. A lot assaying at 98.5% against a 100% reference has PF = 1.0152; a lot at 102.0% has PF = 0.9804. PF compounds with Loss-on-Drying compensation and Salt-to-Base Conversion Factor, and the order in which the factors are applied matters. PF lives on the lot record, not the item record — every receipt updates it from the supplier CoA, every in-house re-assay can override it under change control, and every dispense the lot is used in cites the PF that was active at the moment the kiosk computed the adjusted target. The regulatory anchor sits at 21 CFR 211.84(d)(2) (component testing 'for conformity with all appropriate written specifications for purity, strength, and quality'), 21 CFR 211.101(d) (verifier signature on every weigh-out), 21 CFR 211.103 (yield calculation that has to use the adjusted theoretical), 21 CFR 111.70 / 111.75 (supplement component specifications), and EU GMP Ch.5 §5.40 (starting-materials sampling and identity). This page covers what PF is, how it's computed across all five basis conventions, how it's established and re-established across the lot lifecycle, where it interacts with LOD and salt-to-base, the regulatory overlay across regimes, the eight quiet failure modes that show up as 483 observations (especially in botanical supplements), the KPI suite that proves the programme is alive, and how V5 Ultimate carries PF as a first-class lot attribute that drives every assay-adjusted dispense automatically — with full Part 11 audit trail.

Reviewed · By V5 Ultimate compliance team· 3,700 words · ~17 min read

01What a potency factor actually is

Potency Factor (PF) is the dimensionless scalar that lets a Master Manufacturing Record written for a reference potency be executed against real lots whose certificates of analysis report different measured potencies. The arithmetic is straightforward — PF = reference potency ÷ measured potency, evaluated on a like-for-like basis — but PF is more than the arithmetic. It is the named lot attribute, persistent across the lot lifecycle, that drives every assay-adjusted dispense the lot is used in. A lot's PF can be updated as the lot ages, as it is retested, as repacks happen, or as in-house assay supersedes the supplier CoA. Every dispense cites the PF that was active at the moment the kiosk computed the adjusted target.

A lot assaying at 98.5% against a 100% reference has PF = 1.0152 — meaning the operator must weigh 1.52% more mass than the nominal target to deliver the same active quantity. A lot assaying at 102.0% has PF = 0.9804 — meaning the operator weighs 1.96% less. In both cases the finished batch lands at label claim; without PF, the batch under- or over-delivers silently.

02Five basis conventions PF is computed against

PF is only meaningful when reference and measured potency are on the same basis. There are five conventions in regulated practice; the MMR must specify which one applies to each active, and the lot's CoA must report on the same basis.

BasisCommon inPF formulaPitfall
Anhydrous (water-free)Most APIs, USP/EP monographsPF = 100 / assay% (anhydrous)Lot reported as-is — must combine with LOD compensation.
As-is (manufactured state)Some excipients, simple activesPF = 100 / assay% (as-is)Lot reported anhydrous — silent under-delivery by LOD %.
Free-base (salt form, base claim)Cardiovascular APIs, controlled substancesPF = (100 / assay%) × (MW salt / MW base)Salt factor omitted — silent 5–25% sub-potency.
Marker compoundBotanicals, herbal supplementsPF = marker target % / marker measured %Marker drift across harvest seasons; PF can swing 10–20%.
Activity unit (CFU/IU/U)Probiotics, enzymes, biologicsPF = (target activity per dose × dose count) / lot activity per gramTreating activity-based active like mass-based — most common enzyme blend error.

03How PF gets established across the lot lifecycle

A lot's PF is established at one of four moments and can be re-established as the lot ages.

  1. Supplier CoA import — the most common case. CoA arrives with shipment, the assay value is entered (or auto-parsed from a PDF / CSV / supplier API), PF = reference ÷ measured is computed automatically and stored on the lot record. Reference is taken from the item master.
  2. In-house assay — required under 21 CFR 211.84(d)(2) for at least one identity test per supplier per lot; required for assay if the supplier is not qualified under §211.84(d)(3). The lab result overrides any CoA-derived PF; the override is recorded under change control with the lab's signature.
  3. Pharmacopeial reference — when no CoA exists and no in-house assay can be run (e.g. compounding from a USP-grade powder whose certificate is a pharmacopeial general specification), PF defaults to 1.0 with a deviation note. This is rare and disfavoured.
  4. Re-assay during stability or retest — if the lot is held past its expiry / retest date and an extension assay is performed, the new assay supersedes; PF is updated; the prior PF remains in lot history. Every dispense that used the old PF is unaffected (the record is immutable) but new dispenses use the new PF.

04How PF interacts with LOD and salt-to-base factors

PF rarely acts alone. For most APIs the dispense correction is a composite — PF for assay variability, (1 − LOD)⁻¹ for moisture, and SBF for salt-vs-base — applied in a specific order so rounding doesn't compound.

  1. Normalise salt-to-base (SBF) first — if applicable. Brings the target into salt-mass terms when the label claim is the free base.
  2. Apply anhydrous-basis convert ((1 − LOD)⁻¹) next — brings the target from anhydrous mass to as-is mass.
  3. Apply assay PF last — the final correction for batch-to-batch potency.
  4. Recompute the counter-balance excipient — total batch mass holds.

For a botanical or marker-compound active, the marker assay typically already accounts for moisture (because the marker % is itself on a defined basis declared in the monograph), so LOD compensation may not apply. For a salt-form active sold on the as-is anhydrous basis, only SBF and assay PF apply. The MMR must declare which factors apply per item; the engine applies them in the canonical order; the operator never re-types the math.

05Regulatory overlay across regimes

ClauseRegimeWhat it requires
21 CFR 211.84(d)(2)US human drugsComponents shall be tested for conformity with all appropriate written specifications for purity, strength, and quality. The assay that drives PF is part of this release record.
21 CFR 211.101US human drugsComponents shall be weighed, measured, or subdivided as appropriate; the verifier signature applies to every adjusted weigh-out.
21 CFR 211.103US human drugsYield calculation must use adjusted theoretical (built from PF), not nominal theoretical.
21 CFR 111.70(b)US supplementsComponent specifications must include limits on identity, purity, strength, and composition that the supplement manufacturer establishes — assay range is part of this and feeds PF tolerance.
21 CFR 111.75(a)(2)US supplementsEach lot of dietary ingredient shall be qualified through identity testing and either CoA acceptance under §111.75(a)(2)(i) or in-house testing under §111.75(a)(2)(ii).
21 CFR 111.260(g)US supplementsBatch records shall include the weight or measure of each component used in the manufacturing batch — the adjusted weight, citing PF.
EU GMP Ch.5 §5.40EU medicinal productsStarting materials should be received from approved suppliers and tested or verified before use; the assay is the input to dispensing arithmetic.
EU GMP Ch.5 §5.43EU medicinal productsTheoretical yield and actual yield should be compared at appropriate phases — built from PF-adjusted theoretical.
ICH Q7 §11.2API GMPEach lot of API shall be tested for conformity with specifications; the test result drives any downstream potency adjustment.
USP General Notices 5.50.1Pharmacopeial articlesStrength is expressed in terms of the active moiety; where the article is the salt of an active moiety, strength may be expressed in either form provided the relationship is stated — drives basis convention.

06PF in botanical and herbal supplements — the sharpest case

For botanicals, PF is the most variable and the most operationally important factor. Marker-compound assays (USP <2030>, USP <2750>) report a single marker concentration that stands as a quantitative handle for an otherwise complex matrix. The marker target in the MMR is the planned percentage; the lot marker percentage from the CoA drives PF. Lots from different harvests, different geographies, different ages, and different extraction methods can produce marker drift of 10–20% lot-to-lot. Ignoring that drift produces silent sub-potency in the finished product.

21 CFR 111.70(b)(1) requires the manufacturer to establish identity, purity, strength, and composition specifications for each dietary ingredient — including the marker compound and its target range. 21 CFR 111.75(b) requires verification that the finished batch meets product specifications, which closes the loop. PF is the operational bridge: it converts the MMR's marker-target into the actual mass of botanical to dispense for this particular lot.

07Eight quiet failure modes that produce audit observations

  1. PF stored on item, not on lot — every lot inherits the same factor, batch-to-batch variability is invisible. Architectural failure mode; needs schema fix, not a procedure fix.
  2. PF averaged across multi-lot dispense — when two lots are blended, the engine averages PF instead of applying each lot's PF to its own portion. Silent error.
  3. PF computed against the wrong reference — item master shows 100% reference but the formula was actually validated against a 98% reference (legacy MMR). PF math is right; the target it's correcting toward is wrong.
  4. Basis mismatch between reference and measured — CoA reports anhydrous, item reference is as-is, no LOD compensation applied. PF off by the moisture fraction.
  5. Salt-form confusion — label claim is free base, formula and dispense weigh the salt, PF computed against salt-form assay. Need SBF; PF alone is not enough.
  6. PF override without change control — supervisor overrides the computed PF at the kiosk because the operator 'doesn't trust the CoA'; no documented basis. Part 11 audit failure.
  7. PF not re-baselined after re-assay — extension assay run, new assay value stored on the lot, but PF still showing CoA-receipt value. Engine uses stale PF.
  8. Botanical PF set to 1.0 because marker assay was 'expected' — operator skipped the recalculation step because they assumed marker would meet target. Silent sub-potency.

08The KPI suite that proves the programme is alive

  • PF currency % — fraction of active lots whose PF has been confirmed (CoA-import or in-house assay) within the last X days (target ≥99%).
  • PF spread across lots — variance of PF across active lots of the same item; high spread signals supplier inconsistency and a possible supplier-development action.
  • PF override rate — fraction of dispense events where operator/supervisor overrode the computed PF (target ≤1%; every override is a deviation).
  • In-house vs CoA agreement — fraction of in-house assays that agree with supplier CoA within tolerance (target ≥95%; disagreement triggers supplier scorecard hit).
  • Re-assay coverage % — fraction of lots held past initial retest date that have had an extension assay (target 100%; missing = lot must not dispense).
  • Botanical marker drift — average % drift between lot marker and item target over a rolling window; trend signals harvest variability or supplier change.
  • PF-driven deviation rate — number of deviations opened because computed PF fell outside the formula's allowed window (e.g. PF outside 0.90–1.10).

09How V5 Ultimate runs PF as a first-class lot attribute

  1. Item master holds reference potency, basis (anhydrous / as-is / marker / activity), salt form, free-base MW, salt MW, marker compound, expected marker %, PF tolerance window (e.g. 0.90–1.10), and designated counter-balance partner.
  2. Lot master holds assay %, LOD %, salt-form override, marker %, activity unit value, CoA reference, in-house assay reference, PF (computed), and full PF change history with reason codes.
  3. CoA import (supplier portal upload, CSV, or API) auto-populates assay, LOD, and computes PF — the lot is not released for use until QA reviews and approves.
  4. In-house assay (lab module) can override CoA-derived PF; override is captured under change control with lab signature and reason.
  5. Kiosk dispense screen shows the active PF, its source ('CoA receipt 2026-04-12' or 'in-house re-assay 2026-05-22'), and the adjusted dispense target.
  6. Out-of-tolerance PF (outside the item's allowed window) blocks dispense until QA reviews and explicitly releases or rejects the lot.
  7. Multi-lot dispense applies each lot's own PF to its own portion — no averaging.
  8. BMR/BPR records the PF used on each dispense and the CoA / in-house assay reference, so a regulator can reconstruct the math years later.
  9. PF currency dashboard surfaces lots whose PF is stale (CoA older than threshold) or whose assay is approaching retest expiry.
  10. Botanical-aware: items flagged as botanicals get marker-compound fields, marker-drift trending, and stricter PF tolerance defaults.

Frequently asked questions

Q.Is PF the same as the inverse of assay?+

For simple anhydrous actives, yes — PF = 100 / assay%. For salt-form actives where the label claim is the free base, PF must also include the salt-to-base molecular-weight ratio. For botanicals, PF is the ratio of marker target to marker measured. For activity-based actives, PF flips entirely — it's a mass calculation against activity. The principle is the same; the math varies by basis.

Q.When should PF be recomputed for an existing lot?+

Whenever the underlying assay changes: in-house re-assay supersedes CoA, extension assay after retest expiry, repack that exposes material to humidity and triggers a re-LOD, supplier issues a revised CoA. Every recompute is captured under change control; prior dispenses that used the old PF are immutable; new dispenses use the new PF.

Q.How is PF different from a yield-adjustment factor?+

PF corrects for assay variability of an input; yield-adjustment factor (often called the yield-adjusted batch size) corrects the target batch size of a downstream phase based on the actual yield of the upstream phase. PF is per-lot, per-component; yield-adjustment is per-batch, per-phase. The two are independent and both can apply on the same WO.

Q.What's the relationship between PF and overage?+

Overage is a deliberate, formulation-development-justified excess of active added to compensate for known process losses or stability decay. PF is the per-lot correction for assay variability. The two compose: compute the label-claim equivalent, apply PF + LOD + SBF to get the as-charged adjusted target, then add overage on top. Order matters.

Q.Can the supplier's CoA assay be used as the release assay, or do we always need in-house?+

Under 21 CFR 211.84(d)(2) you must perform identity testing on every lot; for assay you may rely on the supplier's CoA only if the supplier is qualified under §211.84(d)(3) (periodic in-house verification of CoA reliability). For dietary supplements 21 CFR 111.75 is more flexible — you can rely on supplier CoA if the supplier is qualified and you do at least one identity test on every lot. PF is computed from whichever assay is authoritative.

Q.What if our supplier CoA reports assay only to one decimal place — can we still compute PF?+

Yes, but the PF you compute will carry the same precision. Round PF to four decimal places (1.0152) and accept that downstream rounding error is bounded by the assay's reported precision. If the assay precision drives final dispense error above your formulation's tolerance, push the supplier for higher precision or run an in-house assay.

Q.Does PF apply to excipients?+

Rarely. Excipients typically have wide compendial purity ranges and the formulation is not strength-sensitive to excipient potency. The exception is functional excipients (release-controlling polymers, disintegrants whose performance is grade-specific) where the supplier reports a functional spec. Treat the functional spec the same way: reference vs measured, PF, adjusted dispense.

Primary sources

Further reading

See Potency Factor working on a real shop floor

V5 Ultimate ships with the Potency Factor controls already wired in — audit trail, e-signatures, validation evidence. Free trial, no credit card, onboard in days, not months.